What is Rybelsus 7 mg?
Rybelsus 7 mg is an oral prescription medicine containing semaglutide, which belongs to the class of GLP-1 receptor agonists. It is used to help control type 2 diabetes mellitus in adults.
Rybelsus 7 mg is an oral tablet used for managing type 2 diabetes mellitus. It belongs to the class of drugs called GLP-1 receptor agonists (Glucagon-Like Peptide-1).
Unlike most GLP-1 medications that require injection, Rybelsus is the first pill version.
Active Ingredient
-
Semaglutide (7 mg)
Overview of Rybelsus 7 mg
Generic Name: Semaglutide
Brand Name: Rybelsus
Formulation: Oral tablet
How It Works
Rybelsus 7 helps to:
-
Increase insulin release when blood sugar is high
-
Reduce glucose production by the liver
-
Slow stomach emptying, which helps control appetite and weight
Indications
- Rybelsus is indicated for adults with type 2 diabetes to improve glycemic control.
- It can be used alone or in combination with other diabetes medications, particularly when diet and exercise alone do not provide adequate control.
Uses
-
Controls blood sugar levels in adults with type 2 diabetes
-
Helps in weight management (secondary benefit)
-
Reduces the risk of diabetes-related complications (e.g., kidney or heart issues when combined with proper care)
Dosing
-
Usually started with 3 mg once daily (for 30 days)
-
Then increased to 7 mg once daily
-
If needed, may be further increased to 14 mg once daily
Benefits
- Helps achieve better glycemic control in adults with type 2 diabetes.
- May contribute to weight loss as part of a comprehensive treatment plan.
- Provides an oral alternative to injectable GLP-1 receptor agonists.
Important Notes
-
Take it once daily on an empty stomach with a small sip of water (≤ 4 ounces)
-
Wait at least 30 minutes before eating or drinking anything else
-
Not for type 1 diabetes or diabetic ketoacidosis
-
Not typically the first-line treatment (usually given if metformin isn’t enough)
Possible Side Effects
Side Effects
-
Common side effects include:
-
Serious side effects may include:
- Pancreatitis
- Kidney problems
- Allergic reactions
Important Considerations
- Regular monitoring of blood sugar levels is essential.
- Patients should be aware of the signs of pancreatitis and report any severe abdominal pain to their healthcare provider.
- Rybelsus is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
Quick Summary Table
Feature | Details |
---|---|
Medicine Type | Oral GLP-1 receptor agonist |
Strength | 7 mg tablet |
Used For | Type 2 Diabetes |
Main Benefit | Lowers blood sugar, helps with weight control |
Dosing | Once daily, empty stomach |
Not For | Type 1 Diabetes, ketoacidosis |
Common Side Effects | Nausea, stomach upset, diarrhea |